NPT
TMO icon

Nixon Peabody Trust’s Thermo Fisher Scientific TMO Stock Holding History

Nixon Peabody Trust’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.28M Sell
10,529
-1,663
-14% -$798K 0.37% 60
2026
Q1 		$5.99M Sell
12,192
-19,197
-61% -$10.4M 0.48% 54
2025
Q4 		$18.2M Sell
31,389
-844
-3% -$477K 1.38% 20
2025
Q3 		$15.6M Sell
32,233
-177
-0.5% -$82.4K 1.14% 24
2025
Q2 		$13.1M Sell
32,410
-895
-3% -$374K 1.02% 31
2025
Q1 		$16.6M Buy
33,305
+126
+0.4% +$68.2K 1.41% 21
2024
Q4 		$17.3M Sell
33,179
-452
-1% -$249K 1.42% 20
2024
Q3 		$20.8M Buy
33,631
+103
+0.3% +$61K 1.73% 14
2024
Q2 		$18.5M Sell
33,528
-10
-0% -$5.73K 1.65% 17
2024
Q1 		$19.5M Buy
33,538
+1,996
+6% +$1.12M 1.79% 13
2023
Q4 		$16.7M Buy
31,542
+27,402
+662% +$13.3M 1.88% 12
2023
Q3 		$2.1M Sell
4,140
-12
-0.3% -$6.39K 1.75% 23
2023
Q2 		$2.17M Sell
4,152
-1,181
-22% -$637K 1.76% 16
2023
Q1 		$3.07M Buy
5,333
+555
+12% +$313K 2.15% 10
2022
Q4 		$2.63M Sell
4,778
-27
-0.6% -$14.3K 2.13% 9
2022
Q3 		$2.44M Sell
4,805
-4,049
-46% -$2.27M 2.07% 11
2022
Q2 		$4.81M Sell
8,854
-570
-6% -$314K 2.17% 11
2022
Q1 		$5.57M Sell
9,424
-583
-6% -$335K 1.92% 16
2021
Q4 		$6.68M Buy
10,007
+15
+0.2% +$9.37K 2.02% 15
2021
Q3 		$5.71M Buy
9,992
+51
+0.5% +$28K 2.06% 17
2021
Q2 		$5.01M Sell
9,941
-439
-4% -$207K 1.93% 22
2021
Q1 		$4.74M Sell
10,380
-328
-3% -$157K 1.92% 22
2020
Q4 		$4.99M Buy
10,708
+30
+0.3% +$14.1K 2.1% 17
2020
Q3 		$4.71M Sell
10,678
-879
-8% -$363K 2.17% 14
2020
Q2 		$4.19M Buy
11,557
+404
+4% +$135K 2.13% 15
2020
Q1 		$3.16M Buy
11,153
+11
+0.1% +$3.47K 1.95% 21
2019
Q4 		$3.62M Buy
11,142
+5
+0% +$1.52K 1.8% 28
2019
Q3 		$3.24M Buy
11,137
+1,353
+14% +$387K 1.73% 31
2019
Q2 		$2.87M Buy
9,784
+2,531
+35% +$697K 1.62% 34
2019
Q1 		$1.99M Buy
7,253
+1,921
+36% +$478K 1.3% 39
2018
Q4 		$1.19M Sell
5,332
-171
-3% -$40.1K 0.94% 42
2018
Q3 		$1.34M Buy
5,503
+3
+0.1% +$690 0.92% 43
2018
Q2 		$1.14M Buy
5,500
+739
+16% +$157K 0.88% 44
2018
Q1 		$983K Sell
4,761
-156
-3% -$32.7K 0.88% 44
2017
Q4 		$934K Buy
4,917
+182
+4% +$34.9K 0.8% 45
2017
Q3 		$896K Sell
4,735
-195
-4% -$35.3K 0.81% 46
2017
Q2 		$860K Sell
4,930
-30
-0.6% -$5.04K 0.8% 47
2017
Q1 		$762K Sell
4,960
-115
-2% -$17.6K 0.72% 51
2016
Q4 		$716K Buy
5,075
+1,395
+38% +$206K 0.7% 50
2016
Q3 		$585K Sell
3,680
-2,083
-36% -$321K 0.57% 56
2016
Q2 		$852K Buy
5,763
+240
+4% +$35.4K 0.74% 49
2016
Q1 		$782K Buy
5,523
+25
+0.5% +$3.35K 0.7% 52
2015
Q4 		$780K Buy
+5,498
New +$733K 0.71% 53

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Nixon Peabody Trust's TMO Position: Q2 2026 in Review

Nixon Peabody Trust reduced its Thermo Fisher Scientific (TMO) stake by 14% in Q2 2026, selling an estimated $798K and leaving 10,529 shares worth $5.28M. The position accounts for 0.37% of the portfolio, ranked #60.

Nixon Peabody Trust first reported a position in TMO in Q4 2015 and has held it in 43 quarters since. The position peaked at $20.8M in Q3 2024. 963 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Nixon Peabody Trust held 10,529 shares of Thermo Fisher Scientific worth $5.28M as of Q2 2026.
  • Nixon Peabody Trust sold 1,663 Thermo Fisher Scientific shares in Q2 2026, an estimated $798K.
  • Thermo Fisher Scientific made up 0.37% of Nixon Peabody Trust's portfolio in Q2 2026, its #60 holding.
  • Nixon Peabody Trust first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 43 quarters since.
  • Nixon Peabody Trust's Thermo Fisher Scientific position peaked at $20.8M in Q3 2024.
  • 963 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.